Target intelligence / Profile preview

L-arabinose-binding periplasmic protein (AraF) (AraF)

Target
AraF
Molecular classification
Transporter, Periplasmic binding protein, ABC transporter substrate-binding protein
01

Overview

L-arabinose-binding protein AraF (also known as ABP) is a periplasmic substrate-binding protein found in Gram-negative bacteria, most notably Escherichia coli. It serves as the primary receptor for L-arabinose in the high-affinity AraFGH ATP-binding cassette (ABC) transport system, facilitating the uptake of this pentose sugar for catabolism (UniProt P02924). AraF binds L-arabinose with high specificity and affinity, undergoing a Venus flytrap conformational change to deliver the ligand to the membrane-bound permease complex (AraGH) (RCSB PDB 1ABE). While primarily a metabolic protein, AraF is a subject of interest in the development of targeted antimicrobial therapies, such as sugar-drug conjugates that exploit bacterial transport systems for selective drug entry (Preprints.org 2026). It is also a model system for studying protein-carbohydrate interactions and the regulation of bacterial transport under oxidative stress, where its function is modulated by the redox state of its cysteine residues (J. Biol. Chem. 2014). This protein should not be confused with the human A-Raf proto-oncogene (ARAF), which is a serine/threonine kinase involved in the MAPK/ERK signaling pathway and a target in oncology (GeneCards).

Other names
ABPL-arabinose-binding proteinArabinose-binding proteinABC transporter L-arabinose-binding periplasmic protein
02

Mechanism of action

Substrate binding and delivery to the AraGH permease complex of the ABC transporter system

03

Biological functions

L-arabinose transportCarbohydrate bindingSugar metabolismOxidative stress response
04

Disease associations

Bacterial infection
05

Safety considerations

Redundancy with other transport systems (e.g., AraE proton-linked symporter)Potential for off-target effects if used in sugar-drug conjugates
06

Interacting drugs

L-arabinose

2 more in the full profile.

Beyond the preview

Go deeper on L-arabinose-binding periplasmic protein (AraF) (AraF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-arabinose-binding periplasmic protein (AraF) (AraF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call